HDAC9 and neoplasm: For the past few years, histone deacetylase inhibitors (HDACis) have demonstrated broad-spectrum anti-tumor effect by suppressing the activity of HDAC to activate the expression of anti-tumor genes and accelerate the differentiation and apoptosis of tumor cells (SM et al., 2016; Robert et al., 2021; Quinn et al., 2021).